Siegfried plans to grow its exclusive synthesis business in the US by optimizing controlled substance capacity at the Wilmington and nearby Pennsville sites
The platform uses cutting-edge AI and automation to tackle the entire revenue cycle
The successive PLI disbursements validate our disciplined execution and sustained commitment to strengthening India’s domestic pharmaceutical manufacturing capabilities
The collaboration will center on expanding access to Eastman’s Esmeri technology
Artificial intelligence coupled with laboratory automation will transform how scientific work is performed
Backed by two CAP - accredited genomics labs in Delhi NCR and Mumbai, supporting oncology, reproductive health, neurology, transplant immunology, and rare diseases
Supports production of AbbVie's current and next-generation immunology and neuroscience medicines
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
Syrma Johari is a globally recognised medical device engineering and manufacturing organisation
Subscribe To Our Newsletter & Stay Updated
